12:00 AM
 | 
Jun 16, 2014
 |  BC Week In Review  |  Company News  |  Deals

Abzena, Baylor Research Institute deal

Abzena's Antitope Ltd. subsidiary will develop a cell line for the institute's preclinical vaccine targeting dendritic cells to treat head and neck...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >